116 related articles for article (PubMed ID: 14669935)
21. Precision and accuracy of a portable blood analyzer system during cholesterol screening.
Greenland P; Bowley NL; French CA; Meiklejohn B; Gagliano S; Sparks CE
Am J Public Health; 1990 Feb; 80(2):181-4. PubMed ID: 2404422
[TBL] [Abstract][Full Text] [Related]
22. Comparison of two solid phase chemistry systems: Reflotron and Ektachem DT 60.
Rohac M; Gabl F
J Clin Chem Clin Biochem; 1987 Nov; 25(11):811-21. PubMed ID: 2894403
[TBL] [Abstract][Full Text] [Related]
23. Accuracy of Non-Fasting Lipid Profile for the Assessment of Lipoprotein Coronary Risk.
Fatima S; Ijaz A; Sharif TB; Khan DA; Siddique A
J Coll Physicians Surg Pak; 2016 Dec; 26(12):954-957. PubMed ID: 28043305
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the Performance of Two Point-of-Care Analyzers for Total Cholesterol, Triglyceride, and High-Density Lipoprotein Cholesterol Analysis.
Kim H; Kim Y; Park J; Park HI; Lee S; Kim M; Kim Y; Shin S
Clin Lab; 2016 Jul; 62(7):1201-1208. PubMed ID: 28164644
[TBL] [Abstract][Full Text] [Related]
25. Intra-individual variation of plasma lipids and lipoproteins in prepubescent children.
Tolfrey K; Campbell IG; Jones AM
Eur J Appl Physiol Occup Physiol; 1999 Apr; 79(5):449-56. PubMed ID: 10208255
[TBL] [Abstract][Full Text] [Related]
26. Decreased Serum Lipid Levels and Ratios Correlate with Low Prevalence of Coronary Heart Disease in Patients with Parkinson's Disease.
Bao M; Hu R; Chen Y; Wang N; Xue H; He J; Jin J; Kong W; Ke G; Xue Q
Clin Lab; 2018 Sep; 64(9):1413-1419. PubMed ID: 30274018
[TBL] [Abstract][Full Text] [Related]
27. Recommended reference values for serum lipids during early and middle pregnancy: a retrospective study from China.
Wang C; Kong L; Yang Y; Wei Y; Zhu W; Su R; Lin L; Yang H
Lipids Health Dis; 2018 Oct; 17(1):246. PubMed ID: 30382875
[TBL] [Abstract][Full Text] [Related]
28. The accuracy of portable cholesterol analyzers in public screening programs.
Naughton MJ; Luepker RV; Strickland D
JAMA; 1990 Mar; 263(9):1213-7. PubMed ID: 2304236
[TBL] [Abstract][Full Text] [Related]
29. Lipids and lipoproteins in symptomatic coronary heart disease. Distribution, intercorrelations, and significance for risk classification in 6,700 men and 1,500 women. The Bezafibrate Infarction Prevention (BIP) Study Group, Israel.
Circulation; 1992 Sep; 86(3):839-48. PubMed ID: 1516196
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the Olympus AU 400 clinical chemistry analyzer.
Bilić A; Alpeza I; Rukavina AS
Clin Lab; 2000; 46(1-2):1-6. PubMed ID: 10745974
[TBL] [Abstract][Full Text] [Related]
31. Laboratory measurement of lipid and lipoprotein risk factors.
Warnick GR
Scand J Clin Lab Invest Suppl; 1990; 198():9-19. PubMed ID: 2189213
[TBL] [Abstract][Full Text] [Related]
32. Total error assessment of five methods for cholesterol screening.
Miller WG; McKenney JM; Conner MR; Chinchilli VM
Clin Chem; 1993 Feb; 39(2):297-304. PubMed ID: 8432020
[TBL] [Abstract][Full Text] [Related]
33. Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study.
Nejat A; Mirbolouk M; Mohebi R; Hasheminia M; Tohidi M; Saadat N; Azizi F; Hadaegh F
Clin Biochem; 2014 Sep; 47(13-14):1239-44. PubMed ID: 24657509
[TBL] [Abstract][Full Text] [Related]
34. Relationship between plasma lipid concentrations and HDL subclasses.
Yang Y; Yan B; Fu M; Xu Y; Tian Y
Clin Chim Acta; 2005 Apr; 354(1-2):49-58. PubMed ID: 15748599
[TBL] [Abstract][Full Text] [Related]
35. [The gender features of disorders of composition of lipids of blood serum in patients with chronic pathology of kidneys.].
Murkamilov IT; Aytabaiev KA; Fomin VV; Murkamilova ZA; Rayimjanov ZR; Redjapova NA; Yusupov FA; Aydarov ZA
Klin Lab Diagn; 2018; 63(3):152-158. PubMed ID: 30673194
[TBL] [Abstract][Full Text] [Related]
36. How accurately does the Reflotron dry-chemistry system measure plasma total cholesterol levels when used a community-screening device.
Phillips S; Wyndham L; Shaw J; Walker SF
Med J Aust; 1988 Aug; 149(3):122-5. PubMed ID: 3398798
[TBL] [Abstract][Full Text] [Related]
37. Blood lipids in young distance runners.
Eisenmann JC; Womack CJ; Reeves MJ; Pivarnik JM; Malina RM
Med Sci Sports Exerc; 2001 Oct; 33(10):1661-6. PubMed ID: 11581549
[TBL] [Abstract][Full Text] [Related]
38. Performance of the CardioChek PA and Cholestech LDX point-of-care analysers compared to clinical diagnostic laboratory methods for the measurement of lipids.
Panz VR; Raal FJ; Paiker J; Immelman R; Miles H
Cardiovasc J S Afr; 2005; 16(2):112-7. PubMed ID: 15915279
[TBL] [Abstract][Full Text] [Related]
39. A comparison of three desktop chemistry analyzers for the pediatric practice.
Hicks JM; Iosefsohn M; Greenberg L
Clin Pediatr (Phila); 1991 Apr; 30(4):217-24. PubMed ID: 2025985
[TBL] [Abstract][Full Text] [Related]
40. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
